DK1150667T3 - Langkædet cyclohexenonalkohol til behandling af amytrofisk lateralsklerose - Google Patents
Langkædet cyclohexenonalkohol til behandling af amytrofisk lateralskleroseInfo
- Publication number
- DK1150667T3 DK1150667T3 DK00902903T DK00902903T DK1150667T3 DK 1150667 T3 DK1150667 T3 DK 1150667T3 DK 00902903 T DK00902903 T DK 00902903T DK 00902903 T DK00902903 T DK 00902903T DK 1150667 T3 DK1150667 T3 DK 1150667T3
- Authority
- DK
- Denmark
- Prior art keywords
- sup
- lateral sclerosis
- active ingredient
- cyclohexenone
- long
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
- C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
- C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
- C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/713—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3331299 | 1999-02-10 | ||
JP18054699A JP4469441B2 (ja) | 1999-02-10 | 1999-06-25 | 神経変性疾患の予防又は治療薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1150667T3 true DK1150667T3 (da) | 2004-08-30 |
Family
ID=26371993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00902903T DK1150667T3 (da) | 1999-02-10 | 2000-02-10 | Langkædet cyclohexenonalkohol til behandling af amytrofisk lateralsklerose |
Country Status (10)
Country | Link |
---|---|
US (1) | US7166642B1 (zh) |
EP (1) | EP1150667B1 (zh) |
JP (1) | JP4469441B2 (zh) |
AT (1) | ATE270884T1 (zh) |
CA (1) | CA2360246C (zh) |
DE (1) | DE60012143T2 (zh) |
DK (1) | DK1150667T3 (zh) |
ES (1) | ES2223456T3 (zh) |
PT (1) | PT1150667E (zh) |
WO (1) | WO2000047199A1 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4861560B2 (ja) * | 2001-02-19 | 2012-01-25 | 株式会社明治 | 糖尿病合併症治療剤 |
US20040152786A1 (en) * | 2001-05-24 | 2004-08-05 | Bang Luu | Preventive or remedy for diseases caused by cerebrovascular disturbances |
JP4694785B2 (ja) * | 2001-12-13 | 2011-06-08 | フイルメニツヒ ソシエテ アノニム | 活性分子を制御放出するための化合物 |
US7235700B2 (en) | 2003-03-28 | 2007-06-26 | Meiji Dairies Corporation | Process for producing cyclohexenone long-chain alcohols |
FR2860233B1 (fr) * | 2003-09-26 | 2007-10-19 | Univ Pasteur | Composes promoteurs de la differenciation des precurseurs d'oligodendrocytes et modulateurs de l'activation microgliale, compositions et utilisations. |
CN101039663B (zh) | 2004-10-13 | 2012-11-21 | 株式会社明治 | STAT3磷酸化抑制剂和Notch1表达抑制剂 |
EP1829536B1 (en) * | 2004-11-25 | 2011-03-30 | Meiji Dairies Corporation | Ameliorant for renal insufficiency |
DE602006014799D1 (de) * | 2005-01-18 | 2010-07-22 | Meiji Dairies Corp | Heilmittel gegen sensorische erkrankungen |
US20080312336A1 (en) * | 2005-05-26 | 2008-12-18 | Keisuke Satoh | Preventive and/or Therapeutic Agent for Diabetic Vascular Disorder and Respiratory Disorder |
CA2892084C (en) * | 2012-11-21 | 2020-11-10 | Golden Biotechnology Corporation | Methods and compositions for treating neurodegenerative diseases |
US11485696B2 (en) * | 2016-01-22 | 2022-11-01 | Taiho Pharmaceutical Co., Ltd. | Manufacturing method for high-purity cyclohexenone long-chain alcohol |
CN110187044B (zh) * | 2019-01-17 | 2021-04-27 | 山东省农业科学院家禽研究所 | 一种银翘解毒口服液的质量检测方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69026496D1 (de) | 1989-10-13 | 1996-05-15 | Neurofit | Analoge von vitamin a und ihre verwendung, insbesondere als cytotrophische und cytoprotective substanzen sowie diese substanzen enthaltende arzneimittel |
DE69200126D1 (de) | 1992-11-18 | 1994-07-07 | Medafor Illkirch Graffenstaden | Langkettige Fettalkohole mit neurotropischer und gedächtnissfördernder Wirkung. |
US5843641A (en) | 1993-02-26 | 1998-12-01 | Massachusetts Institute Of Technology | Methods for the daignosis, of familial amyotrophic lateral sclerosis |
US5786391A (en) | 1995-01-11 | 1998-07-28 | Cornell Research Foundation, Inc. | Regulating gene expression using retinoids with Ch2 OH or related groups at the side chain terminal position |
US5731354A (en) * | 1996-05-06 | 1998-03-24 | Clarion Pharmaceuticals Inc. | Treatment for the inhibition of neuro-degenerative disease states |
US6228893B1 (en) | 1997-08-13 | 2001-05-08 | Meiji Milk Products Co., Ltd. | Cyclohexenone long-chain alcohol and medicament containing same |
-
1999
- 1999-06-25 JP JP18054699A patent/JP4469441B2/ja not_active Expired - Fee Related
-
2000
- 2000-02-10 EP EP00902903A patent/EP1150667B1/en not_active Expired - Lifetime
- 2000-02-10 AT AT00902903T patent/ATE270884T1/de not_active IP Right Cessation
- 2000-02-10 US US09/890,969 patent/US7166642B1/en not_active Expired - Fee Related
- 2000-02-10 ES ES00902903T patent/ES2223456T3/es not_active Expired - Lifetime
- 2000-02-10 WO PCT/JP2000/000742 patent/WO2000047199A1/en active IP Right Grant
- 2000-02-10 PT PT00902903T patent/PT1150667E/pt unknown
- 2000-02-10 DK DK00902903T patent/DK1150667T3/da active
- 2000-02-10 CA CA002360246A patent/CA2360246C/en not_active Expired - Fee Related
- 2000-02-10 DE DE60012143T patent/DE60012143T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
PT1150667E (pt) | 2004-09-30 |
CA2360246A1 (en) | 2000-08-17 |
CA2360246C (en) | 2008-04-15 |
EP1150667B1 (en) | 2004-07-14 |
EP1150667A1 (en) | 2001-11-07 |
JP2000297034A (ja) | 2000-10-24 |
WO2000047199A1 (en) | 2000-08-17 |
JP4469441B2 (ja) | 2010-05-26 |
DE60012143D1 (de) | 2004-08-19 |
ES2223456T3 (es) | 2005-03-01 |
US7166642B1 (en) | 2007-01-23 |
ATE270884T1 (de) | 2004-07-15 |
DE60012143T2 (de) | 2004-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN05104A1 (fr) | Derives de thiazole pour le traitement de troubles neurodegeneratifs | |
DE69811905D1 (de) | Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel | |
DK1150667T3 (da) | Langkædet cyclohexenonalkohol til behandling af amytrofisk lateralsklerose | |
EP0849256A4 (en) | AMIDE COMPOUNDS AND THEIR USE | |
MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
DE60329316D1 (de) | Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer | |
HUP0400732A2 (hu) | Gyógyászatilag hatékony uridin-észterek | |
HUP0002960A2 (hu) | Aril-oxi-szulfonil-amino-hidroxámsav-származékok | |
MA25809A1 (fr) | Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase | |
MA26956A1 (fr) | Pyrimidine-2,4,6,triones inhibitrices de metalloproteinases. | |
TW200609227A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
HUP0203300A2 (hu) | Immunoszuppresszáns 2,4-diamino-pirimidin vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
WO2002089782A3 (en) | Dioxanes and uses thereof | |
ATE316962T1 (de) | Pyrimidin-derivate als selective inhibitoren von cox-2 | |
NO20025510D0 (no) | Tienodibenzoazulenforbindelser som tumor nekrose faktor inhibitorer | |
MXPA04003611A (es) | Piperidina- y piperazinacetaminas como inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes. | |
HUP0101963A2 (hu) | Interleukin-1béta átalakító enzim szukcinamid inhibitorai | |
DK0674515T3 (da) | Anvendelse af carbostyrilderivater til fremstilling af et medikament til inhibering af interleukin-8 | |
DE60216239T8 (de) | Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie | |
ATE437636T1 (de) | Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen | |
EP1201240A3 (en) | Heterocyclic derivatives useful as pharmaceutical agents | |
DE60238666D1 (de) | Cyclohexenon derivate zur behandlung der diabetischen neuropathie | |
ATE294780T1 (de) | Arylpiperidin- und aryl-1,2,5,6- tetrahydropyridinamid-derivate mit 5ht1a rezeptor aktivität | |
WO2000027378A3 (en) | Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases | |
CA2348319A1 (en) | Cyclohexenol derivative and medicament containing the same |